Himalaya Nutravedics India Limited
ClosedSMEHealthcare · BSE
Himalaya Nutravedics India Ltd is engaged in the manufacturing, marketing, and distribution of Ayurvedic and nutraceutical formulations in India, along with offering third-party contract manufacturing services for other companies in this space. The company has a diversified product portfolio comprising classical Ayurvedic formulations based on traditional texts, proprietary Ayurvedic products, and nutraceutical supplements, available in various dosage forms such as soft gelatin capsules, hard gelatin capsules, tablets, liquid orals, and medicated oils. It operates on a hybrid business model that balances its own branded products with contract manufacturing, supported by an integrated in-house manufacturing facility located in Hyderabad, Telangana. As of September 2025, its products are distributed across multiple states including Telangana, Andhra Pradesh, Kerala, Gujarat, and Uttar Pradesh, with offerings catering to a wide range of wellness segments such as digestive health, immunity, metabolic health, joint care, reproductive health, respiratory wellness, pain management, and overall well-being, aligned with regulatory standards.
Price Band
₹100 – ₹106
Issue Size
₹249.96 L Cr
Lot Size
1200 shares
GMP
—
Est. Listing
₹106
at current GMP
Subscribed
2.33x
overall
Open
22 Sep 2026
Close
24 Sep 2026
Allotment
25 Sep 2026
Refund
26 Sep 2026
Demat Credit
27 Sep 2026
Listing
29 Sep 2026
Last updated 2 days ago
Overall Subscription
2.33x
Total Demand
QIB Multiplier
1.00x
Institutions & Funds
NII / HNI
3.58x
High Net-Worth
Retail (RII)
2.56x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 474,000 | 474,000 | 1.00x |
| NIB | 356,400 | 1,274,400 | 3.58x |
| HNIs(10L +) | 237,600 | 913,200 | 3.84x |
| HNIs (2-10L) | 118,800 | 361,200 | 3.04x |
| RETAIL | 832,800 | 2,133,600 | 2.56x |
| Total | 2,019,600 | 5,156,400 | 2.33x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 347 | 889 | 2.56x |
| HNIs(10L +) | 66 | 47 | 0.71x |
| HNIs (2-10L) | 33 | 93 | 2.82x |
| Total Applications | 446 | 1,029 | 2.31x |
Day-Wise Subscription Progress
About Himalaya Nutravedics India Limited Public Issue & Market Profile
Himalaya Nutravedics India Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹24,99,600 Crores. The shares are offered at a price band of ₹100 to ₹106 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2026-09-24, the basis of allotment is scheduled to be finalized on 2026-09-25. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is the issue size and price band for Himalaya Nutravedics India Limited IPO?
The Himalaya Nutravedics India Limited IPO aggregate issue size is ₹24,99,600 Crores with an equity price band set at ₹100 to ₹106 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,27,200.
How can I check Himalaya Nutravedics India Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. You can track QIB, NII/HNI, and Retail category multiples directly on our dedicated live subscription page.
Where will Himalaya Nutravedics India Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2026-09-25.